We believe technology matters only when it transforms lives. From the very beginning, our mission has been clear: to make diagnostics faster, smarter, and accessible to everyone. Today, that mission has evolved into something deeper empowerment.
Diagnostics is no longer about reacting to disease; it’s about preventing it. Speed alone is not enough. The future lies where portability, data intelligence, and accessibility converge placing knowledge directly into the hands of individuals and healthcare professionals.
At CHIL, we design diagnostic technologies with purpose. Every R&D project starts with a single question: How will this improve real lives? From cancer detection to integrated biosensor systems, our work focuses on closing critical gaps in healthcare and enabling earlier, more accurate intervention.
During the COVID-19 pandemic, this mindset guided us to act decisively becoming one of the world’s first companies to develop and manufacture a global-scale antigen rapid test. It wasn’t just innovation; it was responsibility in action.
We are equally committed to empowering local innovation. Through technology transfer and local production, we help countries build resilient, self-sufficient diagnostic ecosystems strengthening healthcare access while reducing environmental impact.
As digital diagnostics advance, artificial intelligence becomes a powerful ally. At CHIL, we see AI as an extension of human intelligence transforming complex data into clarity, making the invisible visible, and supporting better clinical decisions worldwide.
Our strength comes from people: curious minds, diverse perspectives, and the courage to challenge convention. We invest in talent, mentorship, and scientific growth because innovation flourishes where curiosity is encouraged and ideas are trusted.
The road ahead is clear. Diagnostics will move closer to people into homes, communities, and digital platforms. Data will drive prevention, not just detection.
At CHIL, we are building that future where timely diagnosis is a right, not a privilege.
Because progress in science is not only about technology.
It is about trust, access, and humanity.
Breakthrough begins with curiosity.
And curiosity is where better health starts.
— Dr. Merve Dilmaç Aydın
Chief Technology Officer, CHIL Medical Devices
Test Comment